Friday – Basic Science Track 1A

Name Badge ID(Required)

Full Name(Required)

Enter your first and last names as you would like them to appear on your certificates.

First Last

Email(Required)

Enter the email you used to register for TOXINS 2022.

Please evaluate the speakers

Overall Evaluation

	Excellent	Good	Fair	Poor
Detection of Select Agent Toxins in Support of Public Health Activities (Suzy Kalb)
Monoclonal Antibody Combinations for the Prevention and Treatment of Botulism (Jim Marks)
Fabs From Purified HumAbs Open to the Intrathecal Therapy of Tetanus (Marco Pirazzini)
Novel, Genetically Engineered SNAP-25 Reporter Constructs for BoNT-A and BoNT-E Toxin Activity Measurement (Kimia Hosseini)
Screening and Development of 9-Hydroxy-4H-Pyrido[1,2-a]Pyrimidin-4-One–Based Bifunctional Inhibitors of BoNT-A/LC (Ealin Patel)

Presentation free of commercial bias?

	Yes	No
Detection of Select Agent Toxins in Support of Public Health Activities (Suzy Kalb)
Monoclonal Antibody Combinations for the Prevention and Treatment of Botulism (Jim Marks)
Fabs From Purified HumAbs Open to the Intrathecal Therapy of Tetanus (Marco Pirazzini)
Novel, Genetically Engineered SNAP-25 Reporter Constructs for BoNT-A and BoNT-E Toxin Activity Measurement (Kimia Hosseini)
Screening and Development of 9-Hydroxy-4H-Pyrido[1,2-a]Pyrimidin-4-One–Based Bifunctional Inhibitors of BoNT-A/LC (Ealin Patel)

If you answered “No, this presentation was not free of commercial bias”, on any of the above, please explain your reason(s).

Applicable to my practice/research

	Yes	No
Detection of Select Agent Toxins in Support of Public Health Activities (Suzy Kalb)
Monoclonal Antibody Combinations for the Prevention and Treatment of Botulism (Jim Marks)
Fabs From Purified HumAbs Open to the Intrathecal Therapy of Tetanus (Marco Pirazzini)
Novel, Genetically Engineered SNAP-25 Reporter Constructs for BoNT-A and BoNT-E Toxin Activity Measurement (Kimia Hosseini)
Screening and Development of 9-Hydroxy-4H-Pyrido[1,2-a]Pyrimidin-4-One–Based Bifunctional Inhibitors of BoNT-A/LC (Ealin Patel)

This activity should improve my

	Strongly disagree	Disagree	Neutral	Agree	Strongly agree
Ability to evaluate the latest clinical and scientific research into botulinum neurotoxins
Understanding of the clinical utility of botulinum neurotoxins
Understanding of potential new therapeutic applications of botulinum neurotoxins
Biomedical knowledge of botulinum and other neurotoxins and their application in enhancing therapeutics and improving care

Comments